What causes fuchs eye disease?

Fuchs endothelial corneal dystrophy is a disease of the corneal endothelium's failure to pump fluid out of the cornea, and the causes split into two camps: the genetic mutations that load the gun, and the environmental/mechanical stressors that pull the trigger.

The genetics are the best-characterized piece. The most common culprit is the TCF4 gene, where an expanded trinucleotide repeat (CTG) on chromosome 18 is found in 70-80% of cases in Caucasian populations [1]. This repeat expansion disrupts RNA splicing and produces toxic protein aggregates that poison the endothelial cells over decades [1]. The second major gene is SLC4A11, which encodes a bicarbonate transporter; mutations here cause congenital hereditary endothelial dystrophy type 2, and some late-onset Fuchs cases carry hypomorphic variants in this gene [2]. A 2018 Indian cohort study found ZEB1 and LOXHD1 mutations in a subset of late-onset cases, but those were mostly variants of uncertain significance, meaning the genetic architecture is more diverse in non-Caucasian populations [3]. The COL8A2 gene, encoding collagen type VIII alpha 2, causes early-onset Fuchs (before age 40) through a p.L450W mutation that disrupts the Descemet membrane's structural scaffold [4].

The environmental triggers are where the evidence gets thinner and more contested. The strongest established association is with female sex and age: the disease is 2-3 times more common in women and the prevalence rises from about 4% of people over 40 to over 11% of people over 60 [5]. Estrogen's role is suspected but not proven; the mechanism would be that estrogen increases oxidative stress in endothelial cells, which already have almost no regenerative capacity [5]. Oxidative stress from cumulative UV exposure and smoking is the other well-replicated trigger, with smokers having roughly double the risk of developing Fuchs compared to non-smokers [6]. The mechanism is that reactive oxygen species damage the mitochondrial DNA of endothelial cells, and those cells cannot divide to replace themselves, so the damage accumulates linearly with age [6].

The third piece is the mechanical stress from intraocular surgery. Cataract surgery, especially when complicated by prolonged phacoemulsification time or high phaco power, can accelerate Fuchs in a genetically predisposed eye [7]. The endothelial cell loss from surgery is typically 10-20% in normal eyes, but in Fuchs eyes with already-compromised endothelium, that loss can push the cornea past the decompensation threshold, causing permanent edema and vision loss [7]. This is why the surgical decision is a risk-benefit calculation: the surgeon must weigh the benefit of cataract extraction against the risk of converting a subclinical Fuchs into symptomatic disease.

The evidence is clear on the genetic architecture but thin on the environmental triggers. The TCF4 repeat expansion is the single most important cause, present in the vast majority of cases [1]. The oxidative stress and surgical trauma stories are mechanistically plausible and supported by observational data, but no randomized trial has ever tested whether reducing UV exposure or quitting smoking slows Fuchs progression [6]. The absence of that trial is not evidence of no effect; it is evidence that nobody has bothered to run it.

Confidence: high that TCF4 and SLC4A11 are the major genetic drivers, moderate that oxidative stress and female hormones are the key modifiable triggers, and low on the relative contribution of surgical trauma versus natural history, because the natural history of untreated Fuchs is poorly characterized.